Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China
· Delayed Price · Currency is CNY 12.41
-0.65 (-4.98%)
Apr 30, 2025, 3:00 PM CST
SHA:605199 Market Cap
SHA:605199 has a market cap or net worth of 4.97 billion as of May 2, 2025. Its market cap has increased by 0.89% in one year.
Market Cap
4.97B
Enterprise Value
6.09B
Revenue
1.86B
Ranking
n/a
PE Ratio
42.64
Stock Price
12.41
Market Cap Chart
Since July 10, 2020, SHA:605199's market cap has increased from 2.99B to 4.97B, an increase of 66.13%. That is a compound annual growth rate of 11.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2025 | 4.97B | -22.10% |
| Dec 31, 2024 | 6.37B | 5.08% |
| Dec 29, 2023 | 6.07B | -5.37% |
| Dec 30, 2022 | 6.41B | -35.71% |
| Dec 31, 2021 | 9.97B | 3.32% |
| Dec 31, 2020 | 9.65B | 222.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 324.92B |
| Shenzhen Mindray Bio-Medical Electronics | 265.66B |
| WuXi AppTec | 168.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.88B |
| Aier Eye Hospital Group | 120.68B |
| Sichuan Biokin Pharmaceutical | 114.72B |
| Shanghai United Imaging Healthcare | 108.98B |
| Yunnan Baiyao Group Co.,Ltd | 102.18B |